Study analysis · PLOS One · 2026
Your heart rhythm might be predicting a blind spot in your vision — and doctors are stunned.
Glaucoma patients with a less variable heartbeat were more likely to get a blocked eye vein, but we can't say for sure if the heartbeat causes it.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study looked at people who already had eye problems and noticed that those with a certain type of eye blockage also tended to have a slower heartbeat pattern. But it didn't prove that the slow heartbeat caused the blockage — it might just be that both are linked to something else, like high blood pressure or medicine.
What’s the bottom line?
This study looked at glaucoma patients who got a blocked vein in their eye (RVO) and compared them to those who didn't. They checked heart rhythm patterns and eye blood vessel health.
How strong is this study?
This study tried its best with the data it had, but it looked backward at medical records instead of watching people over time. Because it didn't control for everything that could affect the heart and eyes, and because it had so few people, we can't trust the results to be super reliable — it's more like a hint than a solid answer.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
38 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=63)+5.4/20
- Follow-up+10/10
100 / 100
77 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 553 / 100
Probability of being correct
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
This design cannot establish causation — the findings describe an association, not a cause. This is a retrospective case-control study with no randomization, potential for selection and recall bias, and multivariable analysis failed to identify statistically significant independent predictors. Temporal sequence cannot be definitively established, and confounding factors (e.g., medications, comorbidities) were not fully controlled.
No Conflicts
No conflicts of interest identified
No conflicts of interest or funding disclosures were reported in the study. All methods and analyses appear independently conducted without industry influence.
Independent Analysis Safeguards
- Two retinal specialists independently measured choroidal thickness to minimize inter-observer variability.
- Statistical analyses were performed using SPSS software, and normality was assessed with the Shapiro-Wilk test.
- Multivariable logistic regression was constructed parsimoniously to avoid overfitting.
The study lacks a formal conflict of interest statement or funding disclosure section, which is a limitation in transparency. However, no industry affiliations, funding sources, or author ties to commercial entities are mentioned. The use of standardized, publicly available software (ImageJ) and independent measurements supports methodological integrity.
Key takeaways
- 01
Patients with RVO had much lower heart rhythm variability (SDNN: 22 vs 37 ms) and less blood vessel density in the choroid (64.6% vs 67.5%).
- 02
These differences suggest their bodies may have trouble regulating blood flow, but it's not clear if this directly causes RVO or just happens alongside it.
Surprising findings
- Systemic hypertension showed no predictive power for RVO (AUC: 0.40), while HRV did (AUC: 0.73).Everyone assumes high blood pressure is the main culprit in eye blockages — but here, it performed worse than random chance, while heart rhythm variability was a moderate predictor.
- Baseline vision damage didn’t differ between those who later got RVO and those who didn’t.You’d think worse glaucoma = higher RVO risk, but MD was nearly identical: -5.98 dB vs. -3.70 dB (p=0.114). RVO isn’t just a late-stage glaucoma complication.
Practical takeaways
If you have glaucoma, consider asking your doctor about a simple 5-minute HRV test during your routine visit — it’s non-invasive and may reveal hidden vascular risk.
HRV can be affected by medications (like beta-blockers), stress, sleep, and caffeine — and this study couldn’t control for all of them. Don’t panic over one low reading.
medium confidenceWhy this study matters
Heartbeat Variability = Eye Health Warning Sign?
Glaucoma patients who developed retinal vein occlusion (RVO) had significantly lower heart rate variability: SDNN was 22.12 ± 8.27 ms vs. 36.71 ± 24.74 ms in those without RVO (p=0.002). rMSSD was also lower (16.34 vs. 29.87 ms, p=0.022), suggesting autonomic nervous system dysfunction.
Your heart’s rhythm isn’t just about fitness — it might be a silent indicator of eye disease risk. If your heart can’t adapt quickly, your eye’s blood vessels might be at risk too.
Choroid Blood Flow Drops — But Why?
Patients with RVO had a choroidal vascularity index (CVI) of 64.62% vs. 67.49% in controls (p=0.045), meaning less blood vessel density behind the retina — even though choroidal thickness didn’t differ.
Your eye’s inner blood supply is shrinking before a major blockage happens. This could mean eye health is a window into systemic circulation problems.
The Big Twist: Nothing Predicts RVO Alone
Despite strong univariate links, no variable — not HRV, not CVI, not even high blood pressure — remained statistically significant in multivariable analysis. The study’s own conclusion says: 'no variable retained statistical significance.'
It’s not one bad factor — it’s a hidden combo of things we can’t measure yet. This flips the script on simple 'cause-and-effect' health advice.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
This study looked at glaucoma patients who got a blocked vein in their eye (RVO) and compared them to those who didn't. They checked heart rhythm patterns and eye blood vessel health.
Research results
Patients with RVO had much lower heart rhythm variability (SDNN: 22 vs 37 ms) and less blood vessel density in the choroid (64.6% vs 67.5%).
What this means - more context
These differences suggest their bodies may have trouble regulating blood flow, but it's not clear if this directly causes RVO or just happens alongside it.
This study investigates whether autonomic dysfunction (measured by HRV) and choroidal vascular changes are associated with retinal vein occlusion (RVO) in glaucoma patients.
In a retrospective case-control study of 63 glaucoma patients, those with RVO had significantly lower HRV (SDNN and rMSSD) and lower choroidal vascularity index (CVI) than those without RVO. However, no variable independently predicted RVO in multivariable analysis, and baseline visual field damage did not differ between groups.
Methods Used
Retrospective, single-center case-control study of 29 glaucoma patients with RVO and 34 without. HRV was measured via SDNN and rMSSD; choroidal vascularity index (CVI) was calculated from OCT images. Multivariable logistic regression assessed predictors of RVO.
Main Finding
Glaucoma patients with RVO had significantly lower SDNN (22.12 ± 8.27 ms vs. 36.71 ± 24.74 ms, p=0.002) and rMSSD (16.34 ± 9.55 ms vs. 29.87 ± 31.58 ms, p=0.022), and lower CVI (64.62% ± 7.38% vs. 67.49% ± 5.90%, p=0.045), but no variable remained statistically significant in multivariable analysis.
Confidence Level
Moderate — findings are statistically significant in univariate analysis but not in multivariable analysis; small sample size (n=63) and retrospective design limit causal inference.
Study Flags
Red Flags
- •Retrospective design
- •Small sample size (n=63)
- •No variables remained significant in multivariable analysis
Surprising Findings
Systemic hypertension showed no predictive power for RVO (AUC: 0.40), while HRV did (AUC: 0.73).
Everyone assumes high blood pressure is the main culprit in eye blockages — but here, it performed worse than random chance, while heart rhythm variability was a moderate predictor.
Practical Takeaways
If you have glaucoma, consider asking your doctor about a simple 5-minute HRV test during your routine visit — it’s non-invasive and may reveal hidden vascular risk.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 553 / 100
Probability of being correct
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
Human Case-Control
Subject
Moderate probability
on the GRADE evidence scale
This study looked at people who already had eye problems and noticed that those with a certain type of eye blockage also tended to have a slower heartbeat pattern. But it didn't prove that the slow heartbeat caused the blockage — it might just be that both are linked to something else, like high blood pressure or medicine.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Clear definition of case and control groups
- Use of standardized ophthalmic and HRV measurement tools
- Blinded image analysis for choroidal vascularity index
Weaknesses
- Retrospective design with potential for recall and selection bias
- Small sample size with limited statistical power
- No control for all potential confounders (e.g., specific medications, lifestyle factors)
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
This study looked at glaucoma patients who got a blocked vein in their eye (RVO) and compared them to those who didn't. They checked heart rhythm patterns and eye blood vessel health.
Research results
Patients with RVO had much lower heart rhythm variability (SDNN: 22 vs 37 ms) and less blood vessel density in the choroid (64.6% vs 67.5%).
What this means - more context
These differences suggest their bodies may have trouble regulating blood flow, but it's not clear if this directly causes RVO or just happens alongside it.
This study investigates whether autonomic dysfunction (measured by HRV) and choroidal vascular changes are associated with retinal vein occlusion (RVO) in glaucoma patients.
In a retrospective case-control study of 63 glaucoma patients, those with RVO had significantly lower HRV (SDNN and rMSSD) and lower choroidal vascularity index (CVI) than those without RVO. However, no variable independently predicted RVO in multivariable analysis, and baseline visual field damage did not differ between groups.
Methods Used
Retrospective, single-center case-control study of 29 glaucoma patients with RVO and 34 without. HRV was measured via SDNN and rMSSD; choroidal vascularity index (CVI) was calculated from OCT images. Multivariable logistic regression assessed predictors of RVO.
Main Finding
Glaucoma patients with RVO had significantly lower SDNN (22.12 ± 8.27 ms vs. 36.71 ± 24.74 ms, p=0.002) and rMSSD (16.34 ± 9.55 ms vs. 29.87 ± 31.58 ms, p=0.022), and lower CVI (64.62% ± 7.38% vs. 67.49% ± 5.90%, p=0.045), but no variable remained statistically significant in multivariable analysis.
Confidence Level
Moderate — findings are statistically significant in univariate analysis but not in multivariable analysis; small sample size (n=63) and retrospective design limit causal inference.
Study Flags
Red Flags
- •Retrospective design
- •Small sample size (n=63)
- •No variables remained significant in multivariable analysis
Surprising Findings
Systemic hypertension showed no predictive power for RVO (AUC: 0.40), while HRV did (AUC: 0.73).
Everyone assumes high blood pressure is the main culprit in eye blockages — but here, it performed worse than random chance, while heart rhythm variability was a moderate predictor.
Practical Takeaways
If you have glaucoma, consider asking your doctor about a simple 5-minute HRV test during your routine visit — it’s non-invasive and may reveal hidden vascular risk.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 553 / 100
Probability of being correct
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
Human Case-Control
Subject
Moderate probability
on the GRADE evidence scale
This study looked at people who already had eye problems and noticed that those with a certain type of eye blockage also tended to have a slower heartbeat pattern. But it didn't prove that the slow heartbeat caused the blockage — it might just be that both are linked to something else, like high blood pressure or medicine.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Clear definition of case and control groups
- Use of standardized ophthalmic and HRV measurement tools
- Blinded image analysis for choroidal vascularity index
Weaknesses
- Retrospective design with potential for recall and selection bias
- Small sample size with limited statistical power
- No control for all potential confounders (e.g., specific medications, lifestyle factors)
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
This study tried its best with the data it had, but it looked backward at medical records instead of watching people over time. Because it didn't control for everything that could affect the heart and eyes, and because it had so few people, we can't trust the results to be super reliable — it's more like a hint than a solid answer.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
38 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=63)+5.4/20
- Follow-up+10/10
100 / 100
77 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 553 / 100
Probability of being correct
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
This design cannot establish causation — the findings describe an association, not a cause. This is a retrospective case-control study with no randomization, potential for selection and recall bias, and multivariable analysis failed to identify statistically significant independent predictors. Temporal sequence cannot be definitively established, and confounding factors (e.g., medications, comorbidities) were not fully controlled.
No Conflicts
No conflicts of interest identified
No conflicts of interest or funding disclosures were reported in the study. All methods and analyses appear independently conducted without industry influence.
Independent Analysis Safeguards
- Two retinal specialists independently measured choroidal thickness to minimize inter-observer variability.
- Statistical analyses were performed using SPSS software, and normality was assessed with the Shapiro-Wilk test.
- Multivariable logistic regression was constructed parsimoniously to avoid overfitting.
The study lacks a formal conflict of interest statement or funding disclosure section, which is a limitation in transparency. However, no industry affiliations, funding sources, or author ties to commercial entities are mentioned. The use of standardized, publicly available software (ImageJ) and independent measurements supports methodological integrity.
Standing
Who’s using this study?
The videos and claims on this site that lean on this study, and the researchers who wrote it.
1 video from Doctor Alex cite this study, drawing 1 claim from it.
- Very strong evidence
Randomized or controlled trials support this claim, alongside consistent supporting evidence.
Evidence
Authored by
2 researchersIf this is your work, this is how we attribute it on Fit Body Science. Ji Hye Lee is listed as the lead author.